Primary Care Diabetes
Volume 1, Issue 3 , Pages 155-158 , September 2007

An insight into undiagnosed impaired glucose regulation

  • Alex Doyle

      Affiliations

    • Princess Alexandra Hospital, Department of Medicine, UK
    • Corresponding Author InformationCorresponding author at: Department of Medicine, Princess Alexandra Hospital, Harlow, Essex, CM20 1QX, UK.
    • ,
  • Purnami DeSilva

      Affiliations

    • Princess Alexandra Hospital, Department of Medicine, UK
    • ,
  • David Koduah

      Affiliations

    • Princess Alexandra Hospital, Department of Medicine, UK
    • ,
  • Jagdeep Birdi

      Affiliations

    • Princess Alexandra Hospital, Department of Medicine, UK
    • ,
  • Mazen Sabah

      Affiliations

    • Princess Alexandra Hospital, Department of Medicine, UK
    • ,
  • Richard King

      Affiliations

    • Princess Alexandra Hospital, Department of Biochemistry, UK

Received 21 February 2007 ,Revised 5 July 2007 ,Accepted 10 July 2007.

References 

  1. Bertoni AG, Krop JS, Anderson GF, Brancati FL. Diabetes-related morbidity and mortality in a national sample of U.S. elders. Diabetes Care. 2002;25(3):471–475
  2. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26(3):917–932
  3. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047–1053
  4. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1. Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet. Med. 1998;15(7):539–553
  5. Santaguida PL, Balion C, Hunt D, et al. Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose. Evid. Rep. Technol. Assess. (Summ.). 2005;128:1–11
  6. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N. Engl. J. Med. 2001;344(18):1343–1350
  7. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346(6):393–403
  8. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet. 2002;359(9323):2072–2077
  9. Kaiser T, Sawicki PT. Acarbose for prevention of diabetes, hypertension and cardiovascular events? A critical analysis of the STOP-NIDDM data. Diabetologia. 2004;47(3):575–580
  10. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537–544
  11. Gillies CL, Abrams KR, Lambert PC, et al. Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007;334(7588):299–308
  12. Gerstein HC, Yusif S, Bosch J, et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet. 2006;368(9541):1096–1105
  13. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N. Engl. J. Med. 2007;356(24):2457–2471
  14. Office of National Statistics. The census in England and Wales 2001. Available at: www.statistics.gov.uk. Accessed 24/3/07.
  15. Williams R, Rapport F, Elwyn G, et al. The prevention of type 2 diabetes: general practitioner and practice nurse opinions. Br. J. Gen. Pract. 2004;54(504):531–535
  16. Zhang P, Engelgau MM, Valdez R, et al. Costs of screening for pre-diabetes among US adults: a comparison of different screening strategies. Diabetes Care. 2003;26(9):2536–2542
  17. Khunti K, Ganguli S. Who looks after people with diabetes: primary or secondary care?. J. R. Soc. Med. 2000;93(4):183–186
  18. Wylie G, Hungin AP, Neely J. Impaired glucose tolerance: qualitative and quantitative study of general practitioners’ knowledge and perceptions. BMJ. 2002;324(7347):1190–1192
  19. Smellie WS, Forth J, Bareford DWS, et al. Best practice in primary care pathology: review 3. J. Clin. Pathol. 2006;59(8):781–789

PII: S1751-9918(07)00073-3

doi: 10.1016/j.pcd.2007.07.001

Primary Care Diabetes
Volume 1, Issue 3 , Pages 155-158 , September 2007

Article Tools

* Image Usage & Resolution